Based on these findings, a NF-κB inhibitor like NM may be able to suppress proliferation, angiogenesis, and metastasis both in pancreatic cancer and in other malignancies, opening an avenue for novel therapeutic approaches. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.